Edition:
United Kingdom

STADA Arzneimittel AG (STAGn.DE)

STAGn.DE on Xetra

80.52EUR
10:08am GMT
Change (% chg)

€-0.18 (-0.22%)
Prev Close
€80.70
Open
€80.70
Day's High
€80.70
Day's Low
€80.35
Volume
8,897
Avg. Vol
164,944
52-wk High
€83.91
52-wk Low
€46.31

Latest Key Developments (Source: Significant Developments)

Stada confident domination agreement can be struck in Q1 2018
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Stada :CEO say can confirm medium-term targets.CEO says are confident that a profit and domination agreement with Elliott can be concluded at an EGM in Q1 2018.  Full Article

Stada ‍says is on track to achieve targets for 2017
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Stada Arzneimittel AG says :Stada shows good business development in the third quarter of 2017 and the first nine months.9M sales 1.698 billion eur.‍Well on track to achieve targets for 2017​.Q3 reported group sales ‍554.8​ million eur.‍Q3 adjusted ebitda 109.8​ million eur.‍Q3 adjusted net income 31.2​ million eur.‍Expects key earnings figures in q4 of 2017 to be lower than corresponding figures in q3 of 2017​.‍2017 group sales adjusted for currency and portfolio effects are expected to be in range of euro 2.280 billion to euro 2.350 billio​.‍Sees 2017 adjusted ebitda between euro 430 million and euro 450 million​.‍Sees 2017 adjusted net income between euro 195 million and euro 205 million​.  Full Article

Stada: Bain/Cinven have investor commitments for 19.6 pct of Stada shares
Monday, 10 Jul 2017 

July 10 (Reuters) - Stada :Says Bain Capital has irrevocable tender commitment for 13.36 percent of Stada shares.Stada says Bain and Cinven together have irrevocable investor commitments for 19.6 percent of Stada shares.  Full Article

Stada's board said to consider replacement of CEO - Bloomberg
Tuesday, 4 Jul 2017 

July 4 (Reuters) - Stada :Bloomberg reports Stada's board considering replacement of CEO Wiedenfels.Stada spokesman says won't participate in speculation.  Full Article

Stada CEO confirms wire tapping, says no longer an issue
Wednesday, 29 Mar 2017 

Stada management at press conference : Cfo says expect very strong q1, helped by positive development in russia and germany . CEO says chairman Oetker has never mentioned an ask price of 70 eur per share, management has not voiced a target price . Stada ceo says have no reason to assume that business secrets went into wrong hands as a result of wire tapping . Stada ceo says wire tapping occurred more than 9 month ago, no longer an issue Further company coverage: [STAGn.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

AOC welcomes Stada's move to invite Cinven, Advent to talks
Monday, 13 Feb 2017 

Active Ownership Capital : Says welcomes and supports the initiatives by Stada's management to grow the company’s value Further company coverage: [STAGn.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

New Stada CEO says not in a leadership dispute
Thursday, 4 Aug 2016 

Stada Arzneimittel AG's new CEO Matthias Wiedenfels : Says there is no dispute with previous CEO Retzlaff over leadership of company Further company coverage: [STAGn.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Stada says on the path to reconfigering supervisory board
Wednesday, 6 Jul 2016 

Stada : Stada Arzneimittel AG: important step on the path to reconfiguring the stada supervisory board . Says supervisory board to propose to annual general meeting on august 26, 2016 four candidates for election with a term of office of five years .Says structured process for selection of candidates successfully completed.  Full Article

Stada shareholder says company not acting in the interest of shareholders
Friday, 1 Jul 2016 

Stada shareholder DWS says : Not under the impression that Stada has been acting in the interest of Stada shareholders, would welcome improvement of corporate governance Further company coverage: [STAGn.DE] ((Frankfurt.newsroom@thomsonreuters.com; +49 7565 1272;)).  Full Article

Stada Arzneimittel AG says exec Wiedenfels to replace Retzlaff as CEO
Sunday, 5 Jun 2016 

Stada Arzneimittel AG : Says change in leadership . Says Hartmut Retzlaff lays down office as chief executive officer due to medical reasons . Says executive board members Helmut Kraft, Matthias Wiedenfels jointly take over areas of responsibility overseen by the CEO .Says Matthias Wiedenfels initially appointed by supervisory board as CEO.  Full Article

Photo

Paul Singer's Elliott takes stake in takeover target Uniper

FRANKFURT Activist investor Elliott Management has taken a 5.32 percent stake in Uniper , putting pressure on Finland's Fortum to sweeten its 8.05 billion euro (£422 million) takeover offer for the German energy company.